Genocea Biosciences, Inc.

GNCACIK 0001457612 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0024

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Genocea Biosciences, Inc.

Name	Roles	Filings
Clark William D	OfficerDirector	4
Duvall Diantha	Officer	4
Flechtner Jessica Baker	Officer	4
Aakalu Girish N	Officer	2
Davis Thomas Andrew	Officer	2

Showing 1-5 of 20

Per pagePage 1 of 4Next

All filings

31 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 1, 2022	Siber George Director	SSale	20,425	$0.0653	$1,334
May 26, 2022	Baskett Forest 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	Behbahani Ali Director · 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	Chang Carmen 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	Florence Anthony A. Jr. 10% Owner	SSale	5,931,843	$0.0654	$387,943

Showing 6-10 of 31

Per pagePrevPage 2 of 7Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value